ASX - By Stock
|
HMD |
Re:
Ann: Pause in Trading
|
|
marce
|
3 |
675 |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
3
|
675
|
0
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Defence Contract - $4.2m Cash Received
|
|
marce
|
17 |
4.6K |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
17
|
4.6K
|
0
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Defence Contract - $4.2m Cash Received
|
|
marce
|
17 |
4.6K |
2 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
17
|
4.6K
|
2
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Defence Contract - $4.2m Cash Received
|
|
marce
|
17 |
4.6K |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
17
|
4.6K
|
0
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Defence Contract - $4.2m Cash Received
|
|
marce
|
17 |
4.6K |
1 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
17
|
4.6K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: USA-based Wingwomen signs MoU - launch 'Cardio Care'
|
|
marce
|
24 |
5.3K |
3 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
24
|
5.3K
|
3
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Signed Partner Agreement with Telstra Health
|
|
marce
|
15 |
2.6K |
1 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
15
|
2.6K
|
1
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
marce
|
55 |
22K |
6 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
55
|
22K
|
6
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
marce
|
55 |
22K |
2 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
55
|
22K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Clinical Trial launched at Gold Coast Hospital
|
|
marce
|
23 |
3.3K |
1 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
23
|
3.3K
|
1
|
|
ASX - By Stock
|
AX8 |
Re:
Chart Thread
|
|
marce
|
36 |
18K |
2 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
36
|
18K
|
2
|
|
ASX - By Stock
|
FGR |
Re:
Ann: FGR secures agreement with UKs largest cement manufacturer
|
|
marce
|
29 |
14K |
2 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
29
|
14K
|
2
|
|
ASX - By Stock
|
AX8 |
Re:
Chart Thread
|
|
marce
|
36 |
18K |
0 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
36
|
18K
|
0
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Preliminary Final Report
|
|
marce
|
16 |
6.0K |
4 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
16
|
6.0K
|
4
|
|
ASX - By Stock
|
HMI |
Re:
Ann: Hiremii Delivers Record Revenues and Improved Margin in FY23
|
|
marce
|
26 |
4.9K |
0 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
26
|
4.9K
|
0
|
|
ASX - By Stock
|
VR1 |
Re:
Great awakening
|
|
marce
|
8 |
2.1K |
4 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
8
|
2.1K
|
4
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
marce
|
58 |
11K |
3 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
58
|
11K
|
3
|
|
ASX - By Stock
|
HMD |
Re:
Ann: E-Lovu signs first 3 year commercial agreement
|
|
marce
|
57 |
11K |
2 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
57
|
11K
|
2
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Vection acquisition to lead fashion & retail XR revolution
|
|
marce
|
92 |
29K |
16 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
92
|
29K
|
16
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
marce
|
21 |
8.1K |
3 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
21
|
8.1K
|
3
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
marce
|
21 |
8.1K |
12 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
21
|
8.1K
|
12
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Change of Director's Interest Notice
|
|
marce
|
7 |
1.8K |
1 |
27/03/23 |
27/03/23 |
ASX - By Stock
|
7
|
1.8K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
This time last year...
|
|
marce
|
24 |
4.8K |
0 |
21/01/23 |
21/01/23 |
ASX - By Stock
|
24
|
4.8K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
What are the chances of this company?
|
|
marce
|
107 |
27K |
9 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
107
|
27K
|
9
|
|
ASX - By Stock
|
AX8 |
Re:
Ann: New Targets identified at East Pilbara Lithium Project
|
|
marce
|
6 |
1.9K |
2 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
6
|
1.9K
|
2
|
|
ASX - By Stock
|
AX8 |
Re:
Ann: New Discovery at Woodie Woodie North Manganese Project
|
|
marce
|
5 |
2.0K |
1 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
5
|
2.0K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
marce
|
687 |
253K |
4 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
687
|
253K
|
4
|
|
ASX - By Stock
|
VR1 |
Re:
General Company Chat
|
|
marce
|
2.4K |
790K |
0 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
2.4K
|
790K
|
0
|
|
ASX - By Stock
|
VR1 |
Re:
Vection Technologies (ASX:VR1) Virtual Reality or Virtual Revenue?
|
|
marce
|
316 |
106K |
1 |
25/12/21 |
25/12/21 |
ASX - By Stock
|
316
|
106K
|
1
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Market Update & FY22 Revenue Guidance
|
|
marce
|
53 |
18K |
3 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
53
|
18K
|
3
|
|
ASX - By Stock
|
VR1 |
Re:
General Company Chat
|
|
marce
|
2.4K |
790K |
6 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
2.4K
|
790K
|
6
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Vection TCV Growth Outperforms First Half Objective
|
|
marce
|
165 |
43K |
2 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
165
|
43K
|
2
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Trading Halt
|
|
marce
|
160 |
51K |
1 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
160
|
51K
|
1
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Trading Halt
|
|
marce
|
160 |
51K |
7 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
160
|
51K
|
7
|
|
ASX - By Stock
|
VR1 |
Re:
General Company Chat
|
|
marce
|
2.4K |
790K |
24 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
2.4K
|
790K
|
24
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Vection Unveils Metaverse Release Towards Webex Integration
|
|
marce
|
53 |
18K |
10 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
53
|
18K
|
10
|
|
ASX - By Stock
|
VR1 |
Re:
General Company Chat
|
|
marce
|
2.4K |
790K |
0 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
2.4K
|
790K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: $2.39 million raised via a Convertible Note
|
|
marce
|
31 |
6.8K |
1 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
31
|
6.8K
|
1
|
|
ASX - By Stock
|
VR1 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
marce
|
18 |
7.1K |
3 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
18
|
7.1K
|
3
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Quarterly Activities & Cashflow Report
|
|
marce
|
15 |
3.1K |
4 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
15
|
3.1K
|
4
|
|
ASX - By Stock
|
BCB |
Re:
Ann: Quarterly Activities Report
|
|
marce
|
90 |
22K |
1 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
90
|
22K
|
1
|
|
ASX - By Stock
|
EIQ |
Re:
Ann: Proposed issue of Securities - HWH
|
|
marce
|
7 |
2.3K |
3 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
7
|
2.3K
|
3
|
|
ASX - By Stock
|
VR1 |
Re:
General Company Chat
|
|
marce
|
2.4K |
790K |
3 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
2.4K
|
790K
|
3
|
|
ASX - By Stock
|
BCB |
Re:
Ann: Nick Jorss to lead transition to production
|
|
marce
|
9 |
3.3K |
0 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
9
|
3.3K
|
0
|
|
ASX - By Stock
|
FGR |
Re:
Graphene: Current research and development
|
|
marce
|
451 |
185K |
1 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
451
|
185K
|
1
|
|
ASX - By Stock
|
FGR |
Re:
Graphene: Current research and development
|
|
marce
|
451 |
185K |
0 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
451
|
185K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
marce
|
26 |
4.3K |
3 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
26
|
4.3K
|
3
|
|
ASX - By Stock
|
SP8 |
Re:
Ann: MIGGSTER surpasses 100,000 Paying Subscriber milestone
|
|
marce
|
621 |
111K |
3 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
621
|
111K
|
3
|
|
ASX - By Stock
|
FGR |
Re:
FGR Chart
|
|
marce
|
246 |
99K |
6 |
08/01/21 |
08/01/21 |
ASX - By Stock
|
246
|
99K
|
6
|
|
ASX - By Stock
|
FGR |
Re:
FGR Chart
|
|
marce
|
246 |
99K |
16 |
07/01/21 |
07/01/21 |
ASX - By Stock
|
246
|
99K
|
16
|
|